Episode description

Why does treating a venomous snake bite cost as much as a house? Zachary Crockett slithers over to North Carolina to find out.

• SOURCES:
  • Steve Anderson, emergency medicine business unit leader at BTG Pharmaceuticals.
  • Nick Brandehoff, professor of emergency medicine at the University of Colorado and executive director of the Asclepius Snakebite Foundation.
  • Sean Bush, emergency physician and president of the North American Society of Toxinology.
  • Nitin Deshpande, business consultant with Premium Serums & Vaccines.
  • Jack Facente, owner-operator of AGRITOXINS Venom Production Laboratory.

• RESOURCES:
  • "This New Antivenom Defangs the Toxins of Cobras, Black Mambas and More," by Cassandra Willyard (Scientific American, 2024).
  • "Perspectives on Snakebite Envenoming Care Needs Across Different Sociocultural Contexts and Health Systems: A Comparative Qualitative Analysis Among U.S. and Brazilian Health Providers," by Eleanor Strand, Felipe Murta, Anna Tupetz, Charles J. Gerardo, et al. (Toxicon: X, 2023).
  • "Access to Antivenoms in the Developing World: A Multidisciplinary Analysis," by Julien Potet, David Beran, David J. Williams, et al. (Toxicon: X, 2021).
  • "The Lab Saving the World From Snake Bites," by Myles Karp (Smithsonian Magazine, 2020).
  • "Why Competition Hasn't Brought Down The High Price Of Snakebite Treatment," by Carmen Heredia Rodriguez (NPR, 2019).
  • "Summer Bummer: A Young Camper’s $142,938 Snakebite," by Carmen Heredia Rodriguez (KFF Health News, 2019).
  • "The Amazing Science Behind Fatal Snake Bites," (BBC News, 2015).
  • "Southern Californians See a Rise in Venomous Snakes," by Rebecca Fairley Raney (The New York Times, 2006).
  • Venom Week.

• EXTRAS:
  • Venom Hunters, TV series (2016).